Sign in
4

Changes in Ownership

Lexeo Therapeutics, Inc. Filed Acc 0001209191-24-002929

Options or other derivatives

  • Director acquired 36,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Derivatives
Agger Mette Kirstine Director 2024-02-02 Grant or award · Stock Option (right to buy) +36,000 36,000 D
Loading xslF345X05/doc4.xml…